Harrington Michael J 4

What Happened Michael J. Harrington, a director of Elanco Animal Health Inc. (ELAN), was granted a total of 16,874 equity units on May 21, 2026: 4,678 deferred stock units (DSUs) and 12,196 restricted stock units (RSUs). Both grants are reported as acquisitions at $0.00 per unit (standard for equity awards); no cash changed hands. Footnotes say these were the pro‑rated annual equity awards for non‑employee board members.

Key Details

• Transaction date: 2026-05-21
• Transaction type: Award/Grant (Code A) — 4,678 DSUs and 12,196 RSUs (total 16,874 units)
• Reported acquisition price: $0.00 per unit (grant)
• Footnotes: F1 = pro‑rated deferred stock units for non‑employee directors; F2 = annual restricted stock units for non‑employee directors
• Shares/units owned after transaction: Not specified in the provided filing
• Filing date: 2026-05-26 — the Form 4 was filed five days after the reported transaction. Form 4s are typically due within two business days of the transaction, so this filing appears later than the usual window.

Context DSUs are typically deferred awards that are settled later (often upon departure or at a specified settlement date); RSUs are restricted units that vest according to company rules and convert to shares when vested. These grants are routine director compensation and represent awards rather than purchases or sales, so they are primarily a compensation disclosure rather than a direct indicator of the insider’s market view. No option exercises, sales, or 10b5‑1 plan activity are reported in this filing.